Harson Trading (China) Co., Ltd. (603958.SH) plans to sell 51% equity of Harson Xin Zhi to optimize asset structure.
Hassen Group (603958.SH) announced that the company, Mr. Zhou Zechen, and Mr. Ding Jian intend to transfer their holdings of the company's controlling subsidiary...
Harson Trading (China) Co., Ltd. (603958.SH) announced that the company, Mr. Zhou Zechen, and Mr. Ding Jian intend to transfer 100% equity of Harson Xin Zhi Technology (Yangzhou) Co., Ltd. ("Harson Xin Zhi") to Sipril Information Technology (Baoying) Co., Ltd. ("Sipril Technology"). In this equity transfer, the company will transfer 51% equity of Harson Xin Zhi held by the company to Sipril Technology, and Mr. Zhou Zechen will pay the company for the losses of the target company due to Mr. Zhou Zechen's failure to make the capital contribution. The total transaction price of this transaction is 19.1546 million yuan. The target company is currently mainly engaged in the production, manufacturing, and sales of precision metal parts such as mobile phone motherboards, laptop shells, and new energy vehicle accessories. This transaction is beneficial for optimizing the company's asset structure, reducing operating costs, and controlling risks.
 Related Articles 

On November 4th, IVD MEDICAL (01931) spent 10.31 million Hong Kong dollars to repurchase 1.823 million shares.

TWINTEK (06182) changes ownership, receives a discount of approximately 74.3% for the complete takeover offer, and is scheduled to resume trading on November 5th.

Pfizer Inc. (PFE.US) Q3 earnings exceed expectations and once again raise full-year profit guidance, striving to acquire weight-loss drug company Metsera.
On November 4th, IVD MEDICAL (01931) spent 10.31 million Hong Kong dollars to repurchase 1.823 million shares.

TWINTEK (06182) changes ownership, receives a discount of approximately 74.3% for the complete takeover offer, and is scheduled to resume trading on November 5th.

Pfizer Inc. (PFE.US) Q3 earnings exceed expectations and once again raise full-year profit guidance, striving to acquire weight-loss drug company Metsera.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


